dalteparin has been researched along with Aura in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gersch, K | 1 |
| Spencer, TR | 1 |
2 other studies available for dalteparin and Aura
| Article | Year |
|---|---|
New-onset seizure activity in a transplant patient on immunosuppressive therapy.
Topics: Cystic Fibrosis; Emergency Service, Hospital; Enoxaparin; Epilepsy; Female; Hemorrhage; Humans; Hype | 2020 |
New-onset seizure activity in a transplant patient on immunosuppressive therapy.
Topics: Cystic Fibrosis; Emergency Service, Hospital; Enoxaparin; Epilepsy; Female; Hemorrhage; Humans; Hype | 2020 |